Gts Securities »

SPDR S&P Pharmaceuticals shares owned by Gts Securities

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Gts Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $506k 12k 41.62

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Tesla Motors Put Option (TSLA)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Costco Wholesale Corporation Put Option (COST)

View all positions for Gts Securities

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
Wells Fargo & Company
Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
First Citizens Bank & Trust
Bnp Paribas Arbitrage, Snc
Envestnet Portfolio Solutions
Wharton Business Group
UBS Group
MAI Wealth Advisors
Kingsview Wealth Management
Pnc Financial Services
Royal Bank of Canada
Citadel Advisors
AE Wealth Management

View all funds holding SPDR S&P Pharmaceuticals